Direktorat Registrasi ObatValid

PANTOPRAZOLE SODIUM SESQUIHYDRATE

Claim this product
BPOM Number
GKL2213324244A1
Approved
21 November 2024
Expiry
17 January 2027
Form
SERBUK INJEKSI; 125.30 MG

About This Registration

PANTOPRAZOLE SODIUM SESQUIHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2213324244A1. Its current registration status is Valid, with the licence valid until 17 January 2027. The product is registered to LAPI LABORATORIES - INDONESIA. BPOM first approved this registration in January 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 40 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

PANTOPRAZOLE SODIUM SESQUIHYDRATE (LYOPHILIZED)

Market Intelligence

Owner Portfolio
LAPI LABORATORIES - INDONESIA holds 249 BPOM registrations
Manufacturer Scale
LAPI LABORATORIES - INDONESIA produces 249 registered products
Registration Age
Registered for 4 years, 8 months
Expiry Status
Expires in 3 months

FDA Cross-Reference

via openFDA
Generic Name
PANTOPRAZOLE SODIUM
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1